Jubilant HollisterStier


A North American contract pharmaceutical manufacturer and CMO offering sterile fill-finish, lyophilization, ophthalmic and ointment manufacturing across dual sites in Spokane (WA) and Montréal (QC). Services emphasize GMP/Annex 1 compliance, tech transfer and project management, inspection readiness, supply-chain resilience (including FTZ access), and use of automation and digital tools to support clinical and commercial scale-up.

Industries

N/A

Nr. of Employees

medium (51-250)

Jubilant HollisterStier

Dual sites: Spokane, Washington (USA) and Montréal, Québec (Canada); contact form: https://www.jublhs.com/contact


Services

End-to-end sterile fill-finish production for clinical and commercial sterile drugs, including aseptic and terminal sterilization workflows.

Integrated lyophilization processing with automation and cold-shelf capability to support scale-up of freeze-dried drug products.

Manufacture and filling of ophthalmic products and sterile ointments, including preservative-free formulations and multi-component containers.

End-to-end visual inspection (including automated visual inspection) and secondary packaging tailored to product needs and distribution.

Structured tech transfer and project management to transition products through clinical manufacturing to commercial-scale production.

Supply-chain planning, expedited sourcing, cold-chain logistics management, and FTZ/subzone support to manage tariffs and API importation.

View All Services

Expertise Areas

  • Sterile fill-finish manufacturing
  • Lyophilization and freeze-drying
  • Ophthalmic and topical product manufacturing
  • Aseptic/isolator-based manufacturing
  • Show More (4)

Key Technologies

  • Lyophilization (freeze-drying)
  • Isolator/RABS aseptic containment
  • Automated visual inspection (machine vision)
  • AI-driven predictive maintenance
  • Show More (5)

News & Updates

Attended DCAT Week 2025 to discuss biologics, sterile injectables and lyophilization trends and to meet industry partners.

Article discussing Annex 1 compliance, BioSecure Act uncertainty, AI drug development, tariff-driven supply-chain changes, and pandemic preparedness.

Received the AWB 2024 Manufacturer of the Year award in recognition of manufacturing performance and community engagement.

Public announcement of receiving zero observations from a recent U.S. Food and Drug Administration inspection.

Named Manufacturer of the Year by the Greater Spokane Valley Chamber of Commerce for consecutive years.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.